Management of Extrvasations

Injection site TEAEs, which were generally characterised as injection site pain, pruritus, and erythema, were all mild or moderate in intensity, with most being mild. Table 3 Summary of Treatment-Emergent Adverse Events Reported for at Least 1% of Patients in Either Treatment Group by System Organ Class and Preferred Term (HS-11-421 safety ... ................
................